A genome-wide association study (GWAS) of progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with letrozole (L) with or without bevacizumab (B) in CALGB 40503 Meeting Abstract
| Authors: | Innocenti, F.; Owzar, K.; Jiang, C.; Sibley, A.; Mulkey, F.; Carey, L. A.; Tripathy, D.; Schneider, B. P.; Barry, W. T.; Winer, E. P.; Hudis, C. A.; McLeod, H. L.; Dickler, M. N. |
| Abstract Title: | A genome-wide association study (GWAS) of progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with letrozole (L) with or without bevacizumab (B) in CALGB 40503 |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 18s |
| Language: | English |
| ACCESSION: | WOS:000404665400045 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.538 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 538 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
